קסלודה 150 מ"ג

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Aktiv ingrediens:

CAPECITABINE 150 MG

Tilgjengelig fra:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

ATC-kode:

L01BC06

Legemiddelform:

FILM COATED TABLETS

Administreringsrute:

PER OS

Produsert av:

HOFFMANN LA ROCHE LTD, SWITZERLAND

Terapeutisk gruppe:

CAPECITABINE

Indikasjoner:

Adjuvant Colon Cancer: Xeloda is indicated for the adjuvant treatment of patients following surgery of stage III (Dukesע stage C) colon cancer. Colorectal Cancer: Xeloda is indicated for the treatment of patients with advanced or metastatic colorectal cancer Advanced gastric cancer: Xeloda is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy Breast Cancer Combination Therapy: Xeloda in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. Breast Cancer Monotherapy: Xeloda is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.

Autorisasjon dato:

2010-06-01